# Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan

Study · id `cardio:ct-nct04237493` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04237493](<https://clinicaltrials.gov/study/NCT04237493>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04237493

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 687 participants.

## Technical summary

Registry record NCT04237493. Randomized; no masking; primary purpose treatment. Start 2017-02-14 (actual); primary completion 2017-07-24 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 687 participants (enrolled count; ClinicalTrials.gov record NCT04237493, source copy `cardio:ctgov-nct04237493-2020-02-11`, retrieved 2026-10-26)
- Started: 2017-02-14 (actual) (ClinicalTrials.gov record NCT04237493, source copy `cardio:ctgov-nct04237493-2020-02-11`, retrieved 2026-10-26)
- Primary completion: 2017-07-24 (actual) (ClinicalTrials.gov record NCT04237493, source copy `cardio:ctgov-nct04237493-2020-02-11`, retrieved 2026-10-26)
- Completion: 2017-07-24 (actual) (ClinicalTrials.gov record NCT04237493, source copy `cardio:ctgov-nct04237493-2020-02-11`, retrieved 2026-10-26)
- Countries: Jordan (ClinicalTrials.gov record NCT04237493, source copy `cardio:ctgov-nct04237493-2020-02-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04237493-2020-02-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Metformin and Glimepiride (Low Dosage)
- Intervention (Drug): Metformin and Vildagliptin (Low Dosage)
- Intervention (Drug): Metformin and Insulin Glargine U100 (Low Dosage)
- Intervention (Drug): Metformin, Insulin Glargine U100, and Human Regular Insulin (Low Dosage)
- Intervention (Drug): Metformin and Glimepiride (Regular Dosage)
- Intervention (Drug): Metformin and Vildagliptin (Regular Dosage)
- Intervention (Drug): Metformin and Insulin Glargine U100 (Regular Dosage)
- Intervention (Drug): Metformin, Insulin Glargine U100, and Human Regular Insulin (Regular Dosage)
- Lead sponsor: University of Jordan
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial (`cardio:pubmed-34305809`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e866e1bf3e2729bc40b3962e2bcb4149a43885dbdcd88bdb095e550a3a4d40b7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
